Genomic & Biopharma NewsmicroRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism
|Nature, 2017-02-16 00:00:00|
Scalp cooling can lessen chemotherapy-induced hair loss in some breast cancer patients
Scalp cooling can lessen some chemotherapy-induced hair loss - one of the most devastating hallmarks of cancer - in certain breast cancer patients, according to a new multicenter study from UC San Francisco, Weill Cornell Medicine and three other medical centers.
|News Medical Life Sciences, 2017-02-15 23:47:38|
Research: Nearly 20% of households exhibit double burden of malnutrition in Indonesia
The coexistence of both undernutrition and overweight/obesity, a phenomenon called double burden of malnutrition, is a global public health challenge existing at all levels from the individual to the population, especially in low-to middle-income countries.
|News Medical Life Sciences, 2017-02-15 23:44:10|
Outdoor adventure program may be effective in reducing severity of ASD symptoms, study finds
A new Tel Aviv University study finds outdoor challenge-based interventions may be effective in reducing the overall severity of Autism Spectrum Disorder (ASD) symptoms.
|News Medical Life Sciences, 2017-02-15 23:37:41|
Early Access Program for New Single-Cell Gene Expression Platform Announced
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced an early access program for the BD Resolve™ Single-Cell Gene Expression platform that has the flexibility to capture and analyze hundreds to tens of thousands of individual cells in a broad range of sizes and types. The platform includes reagents ...
|Transcriptome Research & Industry News, 2017-02-15 23:27:19|
International study suggests Nodding syndrome caused by response to parasitic protein
NIH-funded study also identifies potential new mechanism for some forms of epilepsy.
|National Institutes of Health, 2017-02-15 23:00:00|
Early Clinical Data is in from Phase 1 Trials of Galectin-3 Inhibitor GR-MD-02 Immunotherapy
|Immuno-Oncology News, 2017-02-15 21:46:11|
Broad Wins CRISPR Patent Interference Case
The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.
|The Scientist, 2017-02-15 20:25:00|
China facility of Ausmetics hit with FDA warning letter
China facility of Ausmetics hit with FDA warning letter aliu Wed, 02/15/2017 - 15:06
|Fierce Pharma, 2017-02-15 20:06:30|